Diagnosis of pancreatic and biliary tract cancers is complex and challenging due to the lack of symptoms and/or the difficulty of direct, invasive, and imaging-based methods of diagnosis. In an effort to develop better diagnostic markers for these diseases, Kim et al analyzed the genome-wide expression of serum microRNAs in patients with pancreatic and biliary tract cancers. Results were published in BMC Medical Genomics.
Researchers investigated profiles of serum microRNAs from patients with pancreatic and biliary tract cancers, and compared the levels found in healthy controls. Read more. . . .